Yesterday Fresenius Medical Care increased by 2.49%, ended the session at $22.23

The US stock market is closed for the Good Friday holiday and resumes Monday. Meanwhile, here is a recap of yesterday: bullish sentiment helped the kidney dialysis specialist to hammer out a noteworthy $22.03 to $22.25 range yesterday, and finally closing at $22.23 to end the session.

Fresenius Medical Care's uptick comes amid good United States macroeconomic data released during the day — data for United States Unemployment Rate published today at 12:30 UTC came out at 3.5, beating projections of 3.6 and showing improvement over the preceding figure of 3.6.

On the flip side, highly important Non Farm Payrolls data from United States beat analyst expectations of 239,000 with a reading of 236,000. United States Initial Jobless Claims improved upon its previous reading of 246,000 with a new data release of 228,000.

A study of Fresenius Medical Care's chart reveals various key levels to watch: Fresenius Medical Care AG & Co. KGaA could be slowing down soon; it is getting close to the resistance line and is now at $22.31, only 8 cents away. Crossing the resistance line could, however, suggest that further gains are ahead. Concerning technical analysis and more specifically, trend indicators, the Commodity Channel Index (CCI) indicator is above +100, meaning the market price is unusually high compared to the rolling average. Momentum evaluation shows that the Relative Strength Index indicates Fresenius Medical Care is in an overbought condition. According to asset volatility analysis, Bollinger Band® analysis indicates that current price action is approaching the upper band at $22.38, thereby suggesting that Fresenius Medical Care is becoming overvalued.

Notwithstanding Fresenius Medical Care's appreciation in recent days, the technical outlook suggests its bullish run is now fading.

A look at other health care stocks also showed bullish price action as Bristol-Myers Squibb Company added 2.15% to its value, and traded at $70.74. Sanofi gained 2%, as it traded at $55.93. Eli Lilly and Company was up 1.67%.

The stock has been trending positively for about a month. The US-German healthcare company has gained 39.31% since its lowest print of $12.81 earlier this year.